WASHINGTON (AP) — The US Food and Drug Administration advisory panel now endorses booster doses of Johnson & Johnson's single-shot COVID-19 vaccine.

The decision came via a unanimous Friday vote by the panel.

The booster is recommended at least two months after people receive the first dose.

A portion of this story is shared with you as a digital media exclusive. The full story will be available tomorrow for subscribers. Please consider supporting our local, independent newsroom by subscribing at butlereagle.com.